What GENUI Partners does

GENUI Partners is a privately held private investment firm headquartered in Hamburg, Germany, with a regional office in Zürich, Switzerland. Founded in 2014 by a group of investors and entrepreneurs who had previously built market-leading companies, the firm focuses on equity investments in German and German-speaking Mittelstand companies operating in three thematic areas: Healthcare (Good Health), Digitalization, and Sustainable Transformation. Since 2019, GENUI has positioned itself as a European pioneer combining Buyout and Impact investing, evaluating portfolio company impact independently alongside financial performance.

The firm does not develop proprietary technology products. Instead, its investment product is capital combined with operating support: a network of over 30 successful entrepreneurs (GENUI Entrepreneurs) co-invest alongside GENUI and serve on professional advisory boards ("Unternehmer-Beiräte") for portfolio companies. The current and historical portfolio spans radiopharmaceuticals (ROTOP Pharmaka), IT client management (Aagon), digital archiving (KGS Software), digital experience platforms (Magnolia), AI content governance (Markup AI), eCommerce search and personalization (FactFinder), measurement technology (Senseca), healthcare services (Permanence Oerlikon, labor team, VALEARA, APELOS), and travel/exhibition services (Berge & Meer, BRACE Group).

GENUI's revenue mechanics are typical of a private equity manager: returns are generated through successful exits of portfolio companies (including the Cherry IPO in 2021, fashionette in 2022, the sale of Westbridge Advisory to Permira in 2025, and the sale of labor team to Galenica in July 2025), supplemented by management fees on committed/invested capital and carried interest. Distribution and deal flow are driven by the GENUI Entrepreneur network and direct founder engagement rather than traditional sales channels, with marketing via LinkedIn, owned content, and selective LP events such as Super Breakfast during Super Return Berlin. The firm is also the initiator and shareholder of the Unternehmer Stiftung für Chancengerechtigkeit (USC) impact foundation, in which aligned PE returns flow 100% to charitable purposes.

Name

GENUI Partners

Legal name

GENUI GmbH

Website

http://www.genui.de/en/

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

GENUI Partners is a Hamburg-based private equity firm founded in 2014 that invests in market-leading German and Swiss Mittelstand companies in Healthcare, Digitalization, and Sustainable Transformation, combining Buyout and Impact investing alongside a network of over 30 entrepreneur co-investors who serve on portfolio advisory boards.

Ownership category

akta.pro rank

Product category

Private Equity / Impact Investing

NAICS

Portfolio Management and Investment Advice (523940), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282)

akta.pro primary industry

Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG)

akta.pro secondary industries

Multi-Sector / Generalist Growth Equity (FSANACAO), Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest) (FSAAADAH)

Keywords

• Private equity investing
• Impact investing
• Mittelstand buyout
• Sustainable transformation investing
• Healthcare digitalization investments

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Portfolio company exits and capital gains: GENUI generates returns through successful exits of portfolio companies, realizing capital gains on investments in Mittelstand companies. The firm has completed multiple exits including Cherry (IPO 2021), fashionette (2022), Westbridge Advisory (sold to Permira in 2025), and labor team (sold to Galenica in 2025).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

GENUI Partners is a private investment firm that makes majority and significant equity investments in market-leading German Mittelstand (mid-sized) companies, with a focus on three thematic areas: Healthcare, Digitalization, and Sustainable Transformation. The firm combines Buyout and Impact investing, providing capital alongside hands-on advisory board support through a network of over 30 GENUI Entrepreneurs who co-invest and participate in all phases of the investment process. Returns are realized through portfolio company exits, including IPOs, trade sales, and secondary buyouts.

Product overview

GENUI Partners operates as an impact-focused private equity firm that invests in mid-sized market-leading companies in the fields of Healthcare (Gute Gesundheit), Digitalization, and Sustainable Transformation. The firm does not offer a unified technology product but holds investments in various software and technology companies including ACMP (client management software), Magnolia CMS (digital experience platform), Markup AI (content governance platform), FactFinder (eCommerce search and personalization), and Market Logic (marketing information systems). GENUI combines buyout and impact investing approaches, working with entrepreneurs through advisory boards to support sustainable growth.

Differentiator

Problem solved

Functional benefit

Products and services

• Private Equity Buyout Investments

Quantifiable outcome

• Successfully exited multiple portfolio companies including Cherry (IPO 2021), fashionette (2022), Westbridge Advisory (sold to Permira 2025), labor team (sold to Galenica 2025)

Named customers9 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor and core.

• GalenicaminorOthers · 16 July 2025Galenica acquired labor team from GENUI in July 2025. This represented a successful exit for GENUI. labor team is one of Switzerland's four largest medical laboratories, founded in 2001, with over 300 employees and headquarters in Goldach near St. Gallen.
• PermiraminorOthers · 2 January 2025Permira acquired Westbridge Advisory from GENUI in January 2025. Westbridge is a leading European energy consulting platform for commercial real estate companies, supporting clients with energy procurement, CO2 improvement, and long-term sustainability goals.
• Unternehmer Stiftung für Chancengerechtigkeit (USC)coreStrategic or Co-development PartnerGENUI is the initiator, shareholder, and active supporter of the USC foundation, which creates fair opportunities for children and youth in Germany. The foundation uses a unique financing model where capital from the GENUI network is invested in Private Equity funds, with management teams waiving fees and profit participation so that 100% of returns flow to charitable purposes. Shareholders include prominent entrepreneurs like Dr. Andreas Jacobs, Ralph Dommermuth (United Internet), and Dr. Thomas Strüngmann (Hexal/BioNTech).

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• capiton AG: Berlin-based mid-market PE firm focused on German Mittelstand companies with typical equity tickets of €20-100M. Directly comparable to GENUI in deal size, regional focus on German-speaking markets, and multi-sector approach including succession situations.
• Quadriga Capital: Munich-based PE firm investing in DACH mid-market companies with focus on succession, growth, and carve-out situations. Directly comparable in size, regional focus, and Mittelstand buyout approach.
• Bencis Capital Partners: Amsterdam-headquartered PE firm with strong DACH and Benelux mid-market focus. Similar fund size and Mittelstand approach, with comparable equity tickets and sector-agnostic investing.
• Argantis GmbH: German mid-market PE firm focused on succession situations and corporate carve-outs in the DACH region. Comparable in regional focus, deal sourcing approach, and Mittelstand target companies.
• Adagia Partners: Paris-based mid-market PE firm focused on French and European Mittelstand-style companies. Comparable in mid-market deal size, sector diversity, and operationally-focused investment approach.
• SHS Capital: Tuebingen-based healthcare-focused PE firm that co-invested with GENUI in ROTOP Pharmaka in January 2025. Comparable as a German mid-market PE firm with strong healthcare sector specialization.
• EMH Partners: Munich-based growth equity firm that co-led GENUI's $27.5M investment in Markup AI in September 2025. Comparable as DACH-focused growth/buyout investor with technology and digitalization exposure.

Emerging players

• Ananda Impact Ventures: Munich-based impact venture capital firm investing in European impact-driven companies. Comparable in combining financial returns with social/environmental impact, though typically smaller ticket sizes than GENUI's buyout focus.
• BonVenture: Germany-based impact investor combining venture and growth capital with social enterprise focus. Comparable in European impact investing thesis, though focused on earlier-stage companies than GENUI's buyout approach.

Broad incumbents

• Gimv: Belgian-listed PE firm investing across European mid-market companies with sector specialization. Comparable in European mid-market focus and Healthcare/Digitalization themes, though larger and publicly traded.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/genui

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries23 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GENUI Partners